Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02159's Days Payable is ranked worse than 77.89% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.105
vs HKSE:02159: 25.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology Days Payable Chart
Mediwelcome Healthcare Management & Technology Annual Data
HKSE:02159 vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediwelcome Healthcare Management & Technology Days Payable vs Healthcare Providers & Services Industry
Mediwelcome Healthcare Management & Technology Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Days Payable of 14.15 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. This is 42% below median its historical median of 24.19. Over the past decade, Mediwelcome Healthcare Management & Technology's Days Payable has ranged from 15.65 to 47.68. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #472 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 77.9%.
Is Mediwelcome Healthcare Management & Technology's Days Payable too high?
Mediwelcome Healthcare Management & Technology's current Days Payable of 14.15 is 42% below median its 10-year median of 24.19. Over the past 10 years, this metric has ranged from a low of 15.65 to a high of 47.68. The Healthcare Providers & Services industry median Days Payable is 57.11. Mediwelcome Healthcare Management & Technology's value of 14.15 is 75.2% below this industry median. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #472 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #472 out of 606 companies for Days Payable. This places Mediwelcome Healthcare Management & Technology in the lower half of its industry. The industry median Days Payable is 57.11. Mediwelcome Healthcare Management & Technology's value of 14.15 is 75.2% below this benchmark. Historically, Mediwelcome Healthcare Management & Technology's own Days Payable has ranged from 15.65 to 47.68 over the past decade. While the company's 10-year median is 24.19 vs. the industry median of 57.11, Mediwelcome Healthcare Management & Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.11, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current Days Payable of 14.15 is 75.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current Days Payable is 14.15, which is 42% below median its own 10-year median of 24.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.70, compared to a current price of HK$1.62 — trading 131.4% above its estimated fair value. The current Days Payable is 14.15, which is 42% below median its 10-year median of 24.19 and 75.2% below the Healthcare Providers & Services industry median of 57.11. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Days Payable is 14.15 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued.
The current stock price of HK$1.62 is trading 131.4% above its estimated GF Value™ of HK$0.70.
GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02159:
Days Payable: 14.15 (42% below median its 10-year median of 24.19)
GF Value™: HK$0.70 vs. price of HK$1.62 (131.4% above fair value)
Industry Position: 75.2% below the Healthcare Providers & Services median (#472 of 606)
No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediwelcome Healthcare Management & Technology Business Description
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
54GF Score
Get the complete analysis for HKSE:02159
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02159 has been successfully added to your 
